Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Firebrick Pharma Limited ( (AU:FRE) ) has provided an announcement.
Firebrick Pharma Limited has announced a proposed issue of securities, consisting of 22,222,222 ordinary fully paid shares and 11,111,113 options expiring on July 4, 2028, with an exercise price of $0.095. This strategic move is aimed at raising capital to support the company’s growth initiatives and strengthen its market position, potentially impacting stakeholders by enhancing the company’s financial resources for future projects.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare products.
Average Trading Volume: 93,735
Technical Sentiment Signal: Buy
For an in-depth examination of FRE stock, go to TipRanks’ Overview page.